Cargando…
CTBP1 strengthens the cisplatin resistance of gastric cancer cells by upregulating RAD51 expression
Drug resistance is a key factor affecting the treatment of gastric cancer. The resistance of gastric cancer cells to anticancer drugs, such as cisplatin (DDP), remains a major challenge to patient recovery. The present study aimed to investigate the roles of C-terminal-binding protein 1 (CTBP1) in t...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490970/ https://www.ncbi.nlm.nih.gov/pubmed/34630717 http://dx.doi.org/10.3892/ol.2021.13071 |